We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 11-20 of 524

Ambry Genetics countersues Myriad Genetics in genetic patent infringement suit

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • August 15 2013

Responding to the patent infringement claims asserted against it by Myriad Genetics, Ambry Genetics Corp. denies that the 15 patents at issue were

ACLU weighs in on patentability of human genes in Myriad Genetics

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • October 3 2012

American Civil Liberties Union (ACLU) attorneys representing the petitioners in The Association for Molecular Pathology v. Myriad Genetics, Inc., No. 12-398 (U.S., docketed October 1, 2012), have filed their petition for review before the U.S. Supreme Court. Information about the Federal Circuit Court of Appeals ruling from which the petition has been filed appears in Issue 41 of this Bulletin

NGOs request march-in rights for patented drug

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • November 1 2012

Four non-governmental organizations (NGOs) have filed a petition with the National Institutes of Health (NIH) requesting that it grant march-in rights under the Bayh-Dole Act for a patented drug that they claim is “a federally funded invention that is much more expensive in the United States than in Canada, Europe or other high-income countries.”

India-based company’s drugs barred from U.S. market

  • Shook Hardy & Bacon LLP
  • -
  • India, USA
  • -
  • January 30 2014

The U.S. Food and Drug Administration (FDA) has prohibited imported drug products from a Ranbaxy Laboratories, Inc. facility in India due to

Moody’s claims “the worst is over” for pharmaceutical companies facing patent cliff

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • October 3 2012

Moody’s Investor Services has reportedly revised its outlook for the global pharmaceutical industry and upgraded it to stable, apparently anticipating that earnings will rebound in 2013 with the slowdown in patent expirations, characterized by many industry observers as the “patent cliff.”

EU Court of Justice nixes patents for stem-cell inventions involving human embryo destruction

  • Shook Hardy & Bacon LLP
  • -
  • European Union
  • -
  • October 20 2011

The European Union (EU) Court of Justice has determined that EU patent law does not protect neural precursor cells and the processes for their production from embryonic stem cells

False-marking plaintiff challenges retroactive application of AIA standing requirement

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • November 17 2011

A Benjamin N. Cardozo School of Law-affiliated non-profit legal services organization, known as the Public Patent Foundation, has filed a pleading in its false-marking lawsuit against the company that makes Tylenol products, challenging the constitutionality of a retroactive America Invents Act (AIA) provision that would divest the non-profit of standing

Asia’s biomedical R&D spend rises, while U.S. investment declines

  • Shook Hardy & Bacon LLP
  • -
  • China, USA
  • -
  • January 9 2014

Researchers have found that the U.S. global share of biomedical research expenditures fell from 51 percent in 2007 to 45 percent in 2012, while China

Indian Supreme Court rules Novartis cancer drug change not patentable

  • Shook Hardy & Bacon LLP
  • -
  • India
  • -
  • April 4 2013

The Supreme Court of India has rejected the patent application filed by Novartis AG for a beta crystalline form of its cancer drug Gleevec, also

News bytes

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • September 22 2011

The U.S. Patent and Trademark Office requests public comment on the burdens of maintaining utility patents for which fees must be paid periodically after the patent is granted